Based on research that took place at Astera Cancer Care, this abstract was authored by ReVital, astwith key support and co-authorship from Astera Cancer Care’s Ellen Ronnen, MD, and Rachel Carroll, APN-BC.
Read MoreAstera Cancer Care, proudly announced the enrollment of the world's very first patient in the expansion phase of the Exelixis, Inc. JEWEL-101 clinical study.
Read MoreAstera Cancer Care, an independent and physician-owned multi-specialty community oncology practice, announced the enrollment of their first patient in the ASCENT-07 clinical study.
Read More